BGLC   $1.01  -5.00% Market Closed

BioNexus Gene Lab Corp
Total Cash 5.41M
totalCashPerShare 0.301
EBITDA -1.46M
Total Debt 451.45K
quickRatio 4.866
currentRatio 5.605
Total Revenue 9.18M
debtToEquity 4.729
Revenue/Share 0.526
ROA -0.10106
ROE -0.28439
grossProfits
freeCashflow -190.55K
operatingCashflow -1.87M
earningsGrowth
revenueGrowth -0.231
grossMargins 0.1388
ebitdaMargins -0.15869
operatingMargins 0.13125
profitMargins -0.24014999
enterpriseValue 1.57M
forwardPE
floatShares 13.78M
sharesOutstanding 17.97M
sharesShort 101.61K
sharesShortPriorMonth 852.15K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.44%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.60%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.54
Price To Book help_outline 0.66
earningsQuarterlyGrowth
netIncomeToCommon -2.21M
trailingEps -0.15%
forwardEps
enterpriseToEbitda -1.07
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 4
lastUpdated Nov. 7, 2024, 3:12 a.m.